The median age of the total study cohort was 64 years, which is older compared to the median age of patients with ALK-positive NSCLC reported in previous studies at ~55 years of age [15,16,17,18,19,59,60,61]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.